Skip to content
← Full study record

NCT05010629 · MORE INFO

Limitations, agreements, and source contact

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma · Source last updated 2026-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Smaller overall sample size limiting some subgroup analyses.
point Of Contact
email
glenn_hanna@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-3090
title
Glenn J. Hanna
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Smaller overall sample size limiting some subgroup analyses.
point Of Contact
email
glenn_hanna@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-3090
title
Glenn J. Hanna

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Independent clinical review pending · Not medical advice